Cargando...
KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
KRAS is a driver mutation for malignant transformation. It is found in 30% of all cancers and in 90% of pancreatic cancers. The identification of small molecules selectively inhibiting KRAS mutants has been challenging, yet mutant KRAS has recently been shown to be targeted by tumor-infiltrating lym...
Guardado en:
| Publicado en: | Front Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156365/ https://ncbi.nlm.nih.gov/pubmed/30283732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00384 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|